Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM)
TimesSquare Capital Management, an equity investment management company, released its “U.S.
Posts Tagged ‘NASDAQ:INSM’
10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds
On June 9, Reuters reported that Philips' Future Health Index survey concluded that artificial intelligence improved clinical accuracy and increased patient capacity.
10 Most Promising Healthcare Stocks According to Wall Street Analysts
The US healthcare sector has trailed the broader market for three consecutive years, returning just 0.3% in 2023, 0.9% in 2024, and 12.5% in 2025.
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller
What sets billionaire Stanley Druckenmiller apart from other Wall Street giants is his frankness, humility, and openness to learn.
11 Best Long Term US Stocks to Buy Right Now
The Franklin Templeton report said long-term investing has usually rewarded patient investors. Markets go through rough periods, as recessions and bear markets happen.
10 Stocks With Stunning Gains
Ten stocks boasted strong gains on Tuesday, outperforming a lackluster performance on Wall Street, as investors continued to digest a flurry of strong corporate earnings.
8 Most Promising Biotech Stocks to Buy Now
On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity and stronger deal-making as legislative risks ease.
Insmed Incorporated (NASDAQ:INSM) Q1 2026 Earnings Call Transcript
Operator: Thank you for standing by. My name is Danica, and I will be your conference operator today.
Billionaire Druckenmiller and Jim Cramer Like These Stocks
Stanley Druckenmiller and Jim Cramer are two of the closely followed voices in financial markets.
Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models
TheFly reported on April 16 that Guggenheim Securities increased its price target on INSM from $227 to $230 while maintaining a Buy rating.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more...
9 Best QQQ Stocks to Buy Now
On April 8, Yung-Yu Ma of PNC joined 'Fast Money' on CNBC to discuss the current market environment and noted that worst-case scenarios are not yet priced into the VIX or oil ...
Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential
Stanley Druckenmiller, the founder of New York-based Duquesne Family Office, oversees a 13F portfolio at his hedge fund that was worth close to $4.5 billion at the end of the ...
Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why
Insmed Incorporated (NASDAQ:INSM) is one of the best high growth healthcare stocks to buy now. Stifel raised the price target on Insmed Incorporated (NASDAQ:INSM) to $208 from...
Insmed (INSM) Jumps as Morgan Stanley Raises PT by 28%
Insmed snapped a two-day losing streak on Monday, adding 5.52 percent to close at $153.32 apiece, as investors took path from Morgan Stanley’s rating and 28-percent price target...
10 Stocks Leaving the Market in the Dust Today: Insmed, FMC, Alcoa, and More
Ten stocks stood firmer on Monday, clocking gains and bucking a mostly pessimistic broader market, as investors gobbled up shares ahead of dividend payments, while digesting analyst...
11 High Growth Healthcare Stocks to Buy Now
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities...
Artisan Small Cap Fund Sold Insmed (INSM) on Valuation Consideration
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded ...
Insmed Incorporated (INSM) Price Target Raised to $211 at BofA
On February 20, BofA analyst Jason Zemansky raised the firm’s price target on Insmed Incorporated (NASDAQ:INSM) to $211 from $209 and maintained a Buy rating.
10 Stocks That Could Skyrocket in 2026
Investing in stocks with high upside potential is ultimately about capturing asymmetric reward by allocating capital to opportunities where the prospective gains meaningfully ...
Insmed Incorporated (INSM) Enters 2026 With Momentum
Insmed Incorporated (NASDAQ:INSM) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years.
10 Unstoppable Stocks to Buy and Hold for the Next 3 Years
Fundstrat's Tom Lee recently appeared on CNBC Television, highlighting that stocks declined mainly because of the software downturn and a general risk-off as gold surged.
Why Insmed Incorporated (INSM) is One of the Best Strong Buy Healthcare Stocks to Invest In
Insmed Incorporated (NASDAQ:INSM) is one of the best strong buy healthcare stocks to invest in.
11 Best Strong Buy Healthcare Stocks to Invest In
On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the stock market and the recent price action in stocks...
Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”. A copy of the letter can be downloaded here...
Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript February 19, 2026Insmed Incorporated misses on earnings expectations.
Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy
Insmed Inc. (NASDAQ:INSM) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks. On January 23, Roth/MKM began coverage of Insmed Inc.
Stanley Druckenmiller Stock Portfolio: 10 Best Stock Picks
Stanley Druckenmiller originally rose to prominence by managing George Soros' Quantum Fund, where he oversaw the $10 billion currency bet that "broke the Bank of England" in 1992...
Analyst Weighs Patent Cliff Risks Against Insmed’s (INSM) Growth Story
Insmed Inc. (NASDAQ:INSM) is among the best debt-free stocks to buy now.
12 Best Debt-Free Stocks to Buy Now
The growing reliance on debt to finance multi-billion-dollar artificial intelligence and AI-infrastructure investments has come under increasing scrutiny.
Jim Cramer Commented on These 21 S&P 500 and Nasdaq-100 Stocks
Jim Cramer, the host of Mad Money, told viewers on Monday that investors should prioritize owning high-quality stocks and holding onto them, instead of constantly jumping in and...
Insmed (INSM) Rose Following Drug Approval
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter 2025 investor letter.
Here’s What Lifted Insmed Incorporated (INSM) in Q3
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript October 30, 2025Insmed Incorporated misses on earnings expectations.
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook
Insmed rallied for a fourth straight day to reach a new all-time high, as investors took heart from a highly optimistic business outlook for the full-year period, despite widening...
Does Insmed Incorporated (INSM) Have a Promising Pipeline?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Ohio Retirement Fund Invests in Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) is among the most promising biotech stocks to buy according to hedge funds.
7 Most Promising Biotech Stocks to Buy According to Hedge Funds
If there’s one sector that is gaining popularity each day, it’s definitely the biotechnology market.
Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9%
Insmed Incorporated (NASDAQ:INSM) tops our list for being one of the best performing stocks.
12 Best Performing Healthcare Stocks to Buy Right Now
Spending on healthcare in the US is predicted to hit $5.3 trillion this year, making it one of the largest in the world.
RBC Capital Remains Bullish on Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) is one of the best stocks to invest in right now.
Stocks On The Rise: 12 Best Stocks to Invest in Right Now
On September 24, Anastasia Amoroso, Partners Group chief investment strategist, appeared on CNBC’s ‘Squawk Box’ to discuss the latest market trends and the Fed’s interest...
Insmed (INSM) Reported Impressive Results from the Phase 2 Trial of Its Inhalation Powder
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter.
What Does Wall Street Think About Insmed Incorporated (INSM)?
Insmed Incorporated (NASDAQ:INSM) is one of the best hot large cap stocks to buy according to hedge funds.
11 Hot Large Cap Stocks to Buy According to Hedge Funds
On August 30, Ryan Detrick, Carson Group chief market strategist, appeared on CNBC's ‘Closing Bell’ to talk about his thoughts on the markets.
Insmed Incorporated (NASDAQ:INSM) Q2 2025 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q2 2025 Earnings Call Transcript August 7, 2025Insmed Incorporated misses on earnings expectations.
Insmed’s Pipeline Growth With Brensocatib Approval And Phase 3 Trials
New Jersey-based company, Insmed Incorporated (NASDAQ:INSM), is a global biopharmaceutical company developing life‑altering therapies for serious and rare diseases.
Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
10 Stocks with Huge Catalysts on the Horizon
When the president of the US leaves a meeting with the Federal Reserve sounding confident that interest rates will fall, investors cannot help but take notice.
Hedge Fund Resource Center
